The quantitative expression of peroxisome proliferator activated receptor (PPAR) genes in porcine endometrium through the estrous cycle and early pregnancy

Journal of Physiology and Pharmacology

Volumn 62, Issue 5, 2011, Pages 559-565

  Bogacka, I ^a   Bogacki, M ^b  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

; ; Estrous cycle; Implantation; Peroxisome proliferator activated receptors ; Pregnancy; Reproduction

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ESTRUS CYCLE; FEMALE; FIRST TRIMESTER PREGNANCY; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; GILT (SWINE); NONHUMAN; NUCLEOTIDE SEQUENCE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA GENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BETA GENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA1 GENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GENE; QUANTITATIVE GENETICS; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; SOW (SWINE);

ANIMALS; EMBRYO IMPLANTATION; ENDOMETRIUM; ESTROUS CYCLE; FEMALE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR ALPHA; PPAR GAMMA; PPAR-BETA; PREGNANCY; PREGNANCY, ANIMAL; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SUS SCROFA;

EID: 84855737253     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARg. Cell 1995; 83: 803-812.
2. Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptor-alpha and gamma. Proc Natl Acad Sci USA 1997; 94: 4318-4323.
3. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20: 649-88.
4. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992; 358: 771-774.
5. Gearing KL, Gottlicher M, Teboul M, Widmark E, Gustafsson JA. Interaction of the peroxisome-proliferatoractivated receptor and retinoid X receptor. Proc Natl Acad Sci USA 1993; 90: 1440-1444.
6. Escher P, Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 2000; 448: 121-138.
7. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res 2005; 51: 85-94.
8. Isseman I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645-650.
9. Barak Y, Nelson MC, Ong ES, et al. PPARγ is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4: 585-595.
10. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 1995; 5: 571-576.
11. Bogacka I, Ukropcova B, McNeil M, Gimble JM, Smith SR. Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. J Clin Endocrinol Metab 2005; 90: 6650-6656.
12. Bogacka I, Xie H, Bray GA, Smith SR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 2005; 54: 1392-1399.
13. Bogacka I, Gettys TW, de Jonge L, et al. The effect of betaadrenergic and peroxisome proliferator-activated receptorgamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue. Diabetes Care 2007; 30: 1179-1186.
14. Bogacka I, Xie H, Bray GA, Smith SR. The effect of pioglitazone on peroxisome proliferator-activated receptorgamma target genes related to lipid storage in vivo. Diabetes Care 2004; 27: 1660-1667.
15. Sporn MB, Suh N, Mangelsdorf DJ. Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs). Trends Mol Med 2001; 7: 395-400.
16. Fredenrich A, Grimaldi PA. PPAR delta: an uncompletely known nuclear receptor. Diabetes Metab 2005; 31: 23-27.
17. Froment P, Gizard F, Defever D, Staels B, Dupont J, Monget P. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol 2006; 189: 199-209.
18. Komar C. Peroxisome proliferator-activated receptors (PPARs) and ovarian function-implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol 2005; 3: 41.
19. Toth B, Hornung D, Scholz C, Djalali S, Friese K, Jeschke U. Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am J Reprod Immunol 2007; 58: 289-310.
20. Asami-Miyagishi R, Iseki S, Usui M, Uchida K, Kubo H, Morita I. Expression and function of PPARγ in rat placental development. Biochem Biophys Res Commun 2004; 315: 497-501.
21. Nadra K, Anghel SI, Joye E, et al. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor b/d. Mol Cell Biol 2006; 26: 3266-3281.
22. Yang J, Chen L, Zhang X, et al. PPARs and female reproduction: evidence from genetically manipulated mice. PPAR Res 2008; 2008: 723243.
23. Komar CM, Braissant O, Wahli W, Curry TE Jr. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 2001; 142: 4831-4838.
24. Froment P, Fabre S, Dupont J, et al. Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep. Biol Reprod 2003; 69: 1665-1674.
25. Berry EB, Eykholt R, Helliwell RJ, Gilmour RS, Mitchell MD, Marvin KW. Peroxisome proliferator activated receptor isoform expression changes in human gestational tissues with labor at term. Mol Pharmacol 2003; 64: 1586-1590.
26. Lee SS, Pineau T, Drago J, et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15: 3012-3022.
27. Barak Y, Liao D, He W, et al. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 2002; 99: 303-308.
28. Huang JC, Wun WS, Goldsby JS, Wun IC, Noorhasan D, Wu KK. Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activated receptor δ activation: implication in IVF. Hum Reprod 2006; 22: 807-814.
29. Huang JC. The role of peroxisome proliferator-activated receptors in the development and physiology of gametes and preimplantation embryos. PPAR Res 2008; 2008: 732303.
30. Gasic S, Bodenburg Y, Nagamani M, Green A, Urban RJ. Troglitazone inhibits progesterone production in porcine granulose cells. Endocrinology 1998; 139: 4962-4966.
31. Gasic S, Nagamani M, Green A, Urban RJ. Troglitazone is a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase enzyme in the ovary. Am J Obstet Gynecol 2001; 184: 575-579.
32. Komar CM, Curry TE Jr. Localization and expression of messenger RNAs for the peroxisome proliferator-activated receptors in ovarian tissue from naturally cycling and pseudopregnant rats. Biol Reprod 2002; 66: 1531-1539.
33. Xin X, Yang S, Kowalski J, Gerritsen ME. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem 1999; 274: 9116-9121.
34. Shu H, Wong B, Zhou G, et al. Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. Biochem Biophys Res Commun 2000; 267: 345-349.
35. Lohrke B, Viergutz T, Shahi SK, et al. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J Endocrinol 1998; 159: 429-439.
36. Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 2002; 66: 190-198.
37. Kaminska K, Bogacka I, Wasielak M, Bogacki M. Peroxisome proliferator activated receptors and their role in reproduction (in Polish). Med Vet 2008; 64: 533-536.
38. Kaminska K, Wasielak M, Bogacka I, Blitek M, Bogacki M. Quantitative expression of lysophosphatidic acid receptor 3 gene in porcine endometrium during the periimplantation period and estrous cycle. Prostaglandins Other Lipid Mediat 2008; 85: 26-32.
39. Nunez SB, Medin JA, Braissant O, et al. Retinoid X receptor and peroxisome proliferator-activated receptor activate anestrogen responsive gene independent of the estrogen receptor. Mol Cell Endocrinol 1997; 1271: 27-40.
40. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferatoractivated receptor gamma ligands in uterine leiomyoma. Cancer Res 2003; 63: 1221-1227.
41. MacLaren LA, Guzeloglu A, Michel F, Thatcher WW. Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production. Domest Anim Endocrinol 2006; 30: 155-169.
42. Ding NZ, Ma XH, Diao HL, Xu LB, Yang ZM. Differential expression of peroxisome proliferator-activated receptor δ at implantation sites and in decidual cells of rat uterus. Reproduction 2003; 125: 817-825.
43. Ding NZ, Teng CB, Ma H, et al. Peroxisome proliferatoractivated receptor δ expression and regulation in mouse uterus during embryo implantation and decidualization. Mol Reprod Develop 2003; 66: 218-224.
44. Lord E, Murphy BD, Desmarais JA, Ledoux S, Beaudry D, Palin MF. Modulation of peroxisome proliferator activated receptor δ and γ transcripts in swine endometrial tissue during early gestation. Reproduction 2006; 131: 929-942.
45. Sheldrick EL, Derecka K, Marshall E, et al. Peroxisomeproliferator- activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus. Biochem J 2007; 406: 175-183.
46. Keller H, Givel F, Perroud M, Wahli W. Signaling cross-talk between peroxisome proliferator-activated receptor/ retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol 1995; 9: 794-804.
47. Gunin AG, Bitter AD, Demakov AB, Vasilieva EN, Suslonova NV. Effects of peroxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. J Endocrinol 2004; 182: 229-239.
48. Wang X, Kilgore MW. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferatoractivated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 2002; 194: 123-133.
49. Meade EA, McIntyre TM, Zimmerman GA, Prescott SM. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 1999; 274: 8328-8334.
50. Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARβ activators. Nature 1998; 393: 790-793.
51. Bonazzi A, Mastyugin V, Mieyal PA, Dunn MW, Laniado- Schwartzman M. Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J Biol Chem 2000; 275: 2837-2844.
52. Lim H, Gupta RA, Ma WG, et al. Cyclo-oxygenase- 2- derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Develop 1999; 13: 1561-1574.
53. Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997; 91: 197-208.
54. Lim H, Dey SK. A novel pathway of prostacyclin signalinghanging out with nuclear receptors. Endocrinology 2002; 143: 3207-3210.
55. Nishimura K, Yamauchi N, Chowdhury VS, Torii M, Hattori MA, Kaneto M. Expression of peroxisome proliferatoractivated receptor isoforms in the rat uterus during early pregnancy. Cell Tissue Res 2011; 2: 275-284